Interleukin-1 receptor antagonist gene polymorphism in human colorectal cancer

Oncology Reports

Volumn 14, Issue 4, 2005, Pages 915-918

  Viet, Hung Trinh ^a,d   Wågs̈ater, Dick ^b   Hugander, Anders ^c   Dimberg, Jan ^d  

^a VIETNAM NATIONAL UNIVERSITY   (Viet Nam)

^b ÖREBRO UNIVERSITY   (Sweden)

^c RYHOV COUNTY HOSPITAL   (Sweden)

^d Dept of Natural Science and Biomedicine   (Sweden)

Author keywords

Colorectal cancer; Interleukin 1 receptor antagonist; Polymorphism; VNTR

Indexed keywords

CYTOKINE; IL1RN PROTEIN, HUMAN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SIALOGLYCOPROTEIN;

AGAR GEL ELECTROPHORESIS; AGED; ALLELE; ARTICLE; BIOLOGICAL MODEL; COLORECTAL TUMOR; DISEASE COURSE; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; INFLAMMATION; INTRON; MALE; METABOLISM; MIDDLE AGED; NEOPLASM; NUCLEOTIDE REPEAT; POLYMERASE CHAIN REACTION; STATISTICAL MODEL; VARIABLE NUMBER OF TANDEM REPEAT;

AGED; AGED, 80 AND OVER; ALLELES; COLORECTAL NEOPLASMS; CYTOKINES; DISEASE PROGRESSION; ELECTROPHORESIS, AGAR GEL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE FREQUENCY; GENOTYPE; HUMANS; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTRONS; MALE; MIDDLE AGED; MINISATELLITE REPEATS; MODELS, GENETIC; MODELS, STATISTICAL; NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; REPETITIVE SEQUENCES, NUCLEIC ACID; SIALOGLYCOPROTEINS;

EID: 33644829173     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.14.4.915     Document Type: Article

References (35)

1. Fearon ER and Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990.
2. Fodde R, Smits R and Clevers H: APC signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer 1: 55-67, 2001. (Pubitemid 33741881)
3. Balkwill F and Mantovani A: Inflammation and cancer: back to Virchow? Lancet 357: 539-545, 2001. (Pubitemid 32173595)
4. Wilson J and Balkwill F: The role of cytokines in the epithelial cancer microenvironment. Semin Cancer Biol 12: 113-120, 2002. (Pubitemid 34680740)
5. Coussens LM and Werb Z: Inflammation and cancer. Nature 420: 860-867, 2002. (Pubitemid 36019639)
6. Miki C, Tonouchi H, Wakuda R, Hatada T, Wakuda R, Hatada T, Inoue Y, Minato E, Kobayashi M and Kusunoki M: Intratumoral interleukin-6 down-regulation system and genetic mutations of tumor suppressor genes in colorectal carcinoma. Cancer 94: 1584-1592, 2002. (Pubitemid 34212654)
7. Akagi Y, Liu W, Xie K, Zebrowski B, Shaheen RM and Ellis LM: Regulation of vascular endothelial growth factor expression in human colon cancer by interleukin-1β. Br J Cancer 80: 1506-1511, 1999. (Pubitemid 29308627)
8. Lust JA and Donovan KA: The role of interleukin-1β in the pathogenesis of multiple myelom. Hematol Oncol Clin North Am 13: 1117-1125, 1999. (Pubitemid 30017389)
9. Woods KV, Adler-Storthz K, Clayman GL, Francis GM and Grimm EA: Interleukin-1 regulates interleukin-6 secretion in human oral squamous cell carcinoma in vitro: possible influence of p53 but not human papillomavirus E6/E7. Cancer Res 58: 3142-3149, 1998. (Pubitemid 28335098)
10. Waage A, Espevik T and Halstensen A: TNF, IL-1 and IL-6 in human septic shock. Scand J Immunol 28: 267-271, 1988.
11. Sullivan JS, Kilpatrick L, Costarino AT, Lee SC and Harris MC: Correlation of plasma cytokine elevations with mortality rate in children with sepsis. J Pediatr 120: 510-515, 1992.
12. Steinkasserer A, Spurr NK, Cox S, Jeggo P and Sim RB: The human interleukin-1 receptor antagonist (IL1RN) gene maps to chromosome 2q14-q21, in the region of the IL-1α and IL-1β loci. Genomics 13: 654-657, 1992.
13. Eisenberg SP, Brewer M, Verderber E, Heimdal, Brandhuber B J and Thompson RC: Interleukin-1 receptor antagonist is a member of the interleukin 1 gene family. Evolution of a cytokine control mechanism. Proc Natl Acad Sci USA 88: 5232-5236, 1991. (Pubitemid 21914718)
14. Dinarello CA: Biologic basis for interleukin-1 in disease. Blood 87: 2095-2147, 1996.
15. Witkin SS, Gerber S and Ledger WJ: Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis 34: 204-209, 2002. (Pubitemid 34028353)
16. Sehouli J, Mustea A, Könsgen D, Katsares J and Lichtenegger W: Polymorphism of IL-1 receptor antagonist gene: role in cancer. Anticancer Res 22: 3421-3424, 2002. (Pubitemid 36074910)
17. Sehouli J, Mustea A, Koensgen D and Lichtenegger W: Interleukin-1 receptor antagonist gene polymorphism in epithelial ovarian cancer. Cancer Epidemiol Biomarkers 12: 1205-1208, 2003. (Pubitemid 37499445)
18. Ito H and Miki C: Profile of circulating levels of interleukin-1 receptor antagonist and interleukin-6 in colorectal cancer patients. Scand J Gastroenterol 11:1139-1143, 1999. (Pubitemid 29533774)
19. Dinarello C: Interleukin-1 interleukin-1 receptors and interleukin-1 receptor antagonist. Intern Rev Immunol 16: 457-499, 1998.
20. Arend WP: Interleukin 1 receptor antagonist: discovery, structure and properties. Prog Growth Factor Res 2: 193-205, 1990.
21. Janson RW, Hance KR and Arend WP: Production of IL-1 receptor antagonist by human in vitro-derived macrophages. Effects of lipopolysaccaride and granulocyte-macrophage colony-stimulating factor. J Immunol 147: 4218-4223, 1991.
22. Lee BY, Huynh T, Prichard LE, McGuire J and Polan ML: Gonadal steroids modulate interleukin-1 receptor antagonist mRNA expression in cultured human monocytes. Biochem Biophys Res Commun 209: 279-285, 1995.
23. Silvera MR and Phipps RP: Synthesis of interleukin-1 receptor antagonist by Thy-1+ and Thy-1-murine lung fibroblast subsets. J Interferon Cytokine Res 15: 63-70, 1995.
24. Adul M and Hoosein N: Relationship of the interleukin-1 system with neuroendocrine and exocrine markers in human colon cancer cells lines. Cytokine 18: 86-91, 2002.
25. Tarlow JK, Blakemore A, Lennard A, Solari R, Hughes HN, Steinkasserer A and Duff GW: Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 91: 403-404, 1993. (Pubitemid 23177503)
26. Kantarci OH, Atkinson EJ, Hebrink DD, McMurray CT and Weinshenker BG: Association of two variants in IL-1β and IL-1 receptor antagonist genes with multiple sclerosis. J Immunol 106: 220-227, 2000. (Pubitemid 30256096)
27. Bioque G, Crusius JB, Koutroubakis I, Bouma G, Kostense PJ, Meuwissen SG and Pena AS: Allelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clin Exp Immunol 102: 379-383, 1995.
28. Tarlow JK, Cork MJ, Clay FE, Scmitt-Egenolf M, Crane AM, Stierle C, Boehncke WH, Eiermann TH, Blakemore AI, Bleehen SS, Sterry W and Duff GV: Association between interleukin-1 receptor antagonist (IL-1ra) gene polymorphism and early and lateonset psoriasis. Br J Dermatol 136: 147-148, 1997. (Pubitemid 27016208)
29. Garcia-Gonzalez MA, Santolaria LS, Crusius JBA and Serrano MT: The polymorphic IL-1B and IL-1RN genes in the aetiopathogenesis of peptic ulcer. Clin Exp Immunol 125: 368-375, 2001. (Pubitemid 34155432)
30. Apte R and Voronov E: Interleukin 1: a major pleotropic cytokine in tumor-host interactions. Semin Cancer Biol 12: 277-290, 2002. (Pubitemid 35034572)
31. Mustea A, Sehouli J, Könsgen D, Stengel D, Sofroni D and Lichtenegger W: Interleukin 1 receptor antagonist (IL-1RA) polymorphism in women with cervical cancer. Anticancer Res 23: 1099-1102, 2003. (Pubitemid 36752683)
32. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF and Rabkin CS: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404: 398-402, 2000. (Pubitemid 30164342)
33. Vidal-Vanaclocha F, Amezaga C, Asumendi A, Kaplanski G and Dinarello CA: Interleukin-1 receptor blockade reduces the number and size of murine B16 melanoma hepatic metastases. Cancer Res 54: 2667-2672, 1994. (Pubitemid 24173756)
34. Von Biberstein SE, Spiro JD, Lindquist R and Kreutzer DL: Interleukin-1 receptor antagonist in head and neck squamous cell carcinoma. Arch Otolaryngol 122: 751-759, 1996. (Pubitemid 26240021)
35. Iwagaki H, Hizuta A and Tanaka N: Interleukin-1 receptor antagonists and other markers in colorectal cancer patients. Scand J Gastroenterol 32: 577-581, 1997. (Pubitemid 27314269)